OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham, et al.
Transfusion (2022) Vol. 62, Iss. 5, pp. 933-941
Open Access | Times Cited: 18

Showing 18 citing articles:

Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials
Adam C. Levine, Yuriko Fukuta, Moisés A. Huamán, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 12, pp. 2077-2086
Open Access | Times Cited: 39

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
Evan M. Bloch, Daniele Focosi, Shmuel Shoham, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 11, pp. 2018-2024
Open Access | Times Cited: 36

Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25

Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 5

Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox
Evan M. Bloch, David J. Sullivan, Shmuel Shoham, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 19

Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7

Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials
Moisés A. Huamán, Jay S. Raval, James H. Paxton, et al.
Transfusion (2023) Vol. 63, Iss. 9, pp. 1639-1648
Open Access | Times Cited: 7

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7

COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials
Adam C. Levine, Yuriko Fukuta, Moisés A. Huamán, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11

High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3

Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management
Evangelos Terpos, A.R. Branagan, Ramón García‐Sánz, et al.
Seminars in Hematology (2023) Vol. 60, Iss. 2, pp. 107-112
Open Access | Times Cited: 3

Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility
Arwa Z. Al‐Riyami, Lise J Estcourt, Naomi Rahimi‐Levene, et al.
Vox Sanguinis (2022) Vol. 117, Iss. 10, pp. 1202-1210
Open Access | Times Cited: 5

“Something we must be proud of”: An interview and document study of team improvisation in the Dutch convalescent plasma project group
Praiseldy Langi Sasongko, Hans Vrielink, Martine C. de Bruijne
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access

The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks
Anusha Yarava, Christi E. Marshall, Dietmar Reichert, et al.
Journal of Clinical and Translational Science (2024) Vol. 8, Iss. 1
Open Access

Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample
Evan M. Bloch, Ruchika Goel, Xianming Zhu, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 2, pp. 237-241
Open Access | Times Cited: 1

Page 1

Scroll to top